148 related articles for article (PubMed ID: 9809477)
1. Effects of granisetron and its combination with dexamethasone on cisplatin-induced delayed emesis in the ferret.
Fukunaka N; Sagae S; Kudo R; Endo T; Hirafuji M; Minami M
Gen Pharmacol; 1998 Nov; 31(5):775-81. PubMed ID: 9809477
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of zacopride on Cisplatin-induced delayed emesis in ferrets.
Yamakuni H; Nakayama H; Matsui S; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2006 May; 101(1):99-102. PubMed ID: 16651699
[TBL] [Abstract][Full Text] [Related]
3. Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone.
Campos D; Pereira JR; Reinhardt RR; Carracedo C; Poli S; Vogel C; Martinez-Cedillo J; Erazo A; Wittreich J; Eriksson LO; Carides AD; Gertz BJ
J Clin Oncol; 2001 Mar; 19(6):1759-67. PubMed ID: 11251007
[TBL] [Abstract][Full Text] [Related]
4. Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model.
Endo T; Hamaue N; Ihira E; Teramoto Y; Liu Y; Hirafuji M; Minami M
Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):55-68. PubMed ID: 14632314
[TBL] [Abstract][Full Text] [Related]
5. Repeated administration of the 5-HT3 receptor antagonist granisetron reduces the incidence of delayed cisplatin-induced emesis in the piglet.
Grélot L; Le Stunff H; Milano S; Blower PR; Romain D
J Pharmacol Exp Ther; 1996 Oct; 279(1):255-61. PubMed ID: 8859001
[TBL] [Abstract][Full Text] [Related]
6. An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret.
Rudd JA; Naylor RJ
Br J Pharmacol; 1996 May; 118(2):209-14. PubMed ID: 8735616
[TBL] [Abstract][Full Text] [Related]
7. A randomized double-blind trial to compare the clinical efficacy of granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis.
Aapro MS; Thuerlimann B; Sessa C; De Pree C; Bernhard J; Maibach R;
Ann Oncol; 2003 Feb; 14(2):291-7. PubMed ID: 12562658
[TBL] [Abstract][Full Text] [Related]
8. [Combination effect of granisetron plus corticosteroid for prevention of cisplatin-induced emesis: a cross-over study comparing methylprednisolone and dexamethasone].
Tanaka K; Sekine M; Serikawa T; Sanada H; Shichiri K; Fujimori R
Gan To Kagaku Ryoho; 1998 May; 25(6):907-13. PubMed ID: 9617330
[TBL] [Abstract][Full Text] [Related]
9. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
Navari RM; Reinhardt RR; Gralla RJ; Kris MG; Hesketh PJ; Khojasteh A; Kindler H; Grote TH; Pendergrass K; Grunberg SM; Carides AD; Gertz BJ
N Engl J Med; 1999 Jan; 340(3):190-5. PubMed ID: 9917226
[TBL] [Abstract][Full Text] [Related]
10. Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets.
Endo T; Ogawa T; Hamaue N; Akita K; Hirafuji M; Minami M; Blower PR
Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):243-53. PubMed ID: 9730004
[TBL] [Abstract][Full Text] [Related]
11. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
[TBL] [Abstract][Full Text] [Related]
12. Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets.
Endo T; Sugawara J; Nemoto M; Minami M; Blower PR
Res Commun Mol Pathol Pharmacol; 1998 Dec; 102(3):227-39. PubMed ID: 10342910
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-independent model of cisplatin-induced emesis in the ferret.
Rudd JA; Cheng CH; Naylor RJ
Jpn J Pharmacol; 1998 Nov; 78(3):253-60. PubMed ID: 9869258
[TBL] [Abstract][Full Text] [Related]
14. Use of intravenous microdialysis to monitor changes in serotonin release and metabolism induced by cisplatin in cancer patients: comparative effects of granisetron and ondansetron.
Castejon AM; Paez X; Hernandez L; Cubeddu LX
J Pharmacol Exp Ther; 1999 Dec; 291(3):960-6. PubMed ID: 10565811
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, crossover, randomized comparison of granisetron and ramosetron for the prevention of acute and delayed cisplatin-induced emesis in patients with gastrointestinal cancer: is patient preference a better primary endpoint?
Koizumi W; Tanabe S; Nagaba S; Higuchi K; Nakayama N; Saigenji K; Nonaka M; Yago K
Chemotherapy; 2003 Dec; 49(6):316-23. PubMed ID: 14671433
[TBL] [Abstract][Full Text] [Related]
16. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets.
Nakayama H; Yamakuni H; Higaki M; Ishikawa H; Imazumi K; Matsuo M; Mutoh S
J Pharmacol Sci; 2005 Aug; 98(4):396-403. PubMed ID: 16079468
[TBL] [Abstract][Full Text] [Related]
18. The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis.
Haga K; Inaba K; Shoji H; Morimoto Y; Fukuda T; Setoguchi M
Jpn J Pharmacol; 1993 Nov; 63(3):377-83. PubMed ID: 8107329
[TBL] [Abstract][Full Text] [Related]
19. Improvement of cisplatin-induced emesis and delayed gastric emptying by KB-R6933, a novel 5-HT3 receptor antagonist.
Ozaki A; Sukamoto T
Gen Pharmacol; 1999 Sep; 33(3):283-8. PubMed ID: 10480662
[TBL] [Abstract][Full Text] [Related]
20. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
Yoshida N; Omoya H; Ito T
J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]